EntryPoint Capital’s LeMaitre Vascular LMAT Stock Holding History

EntryPoint Capital’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$514K	Sell	4,706 -834	-15%	-$79.5K	0.15%	232
2025 Q4	$449K	Buy	+5,540	New	+$477K	0.18%	208
2025 Q3	–	Sell	-5,580	Closed	-$463K	–	788
2025 Q2	$463K	Buy	5,580 +142	+3%	+$11.9K	0.23%	125
2025 Q1	$456K	Buy	5,438 +998	+22%	+$92.8K	0.21%	132
2024 Q4	$409K	Buy	4,440 +1,633	+58%	+$157K	0.17%	196
2024 Q3	$261K	Buy	+2,807	New	+$243K	0.15%	309
2024 Q1	–	Sell	-80	Closed	-$4.54K	–	1605
2023 Q4	$4.54K	Buy	+80	New	+$4.19K	﹤0.01%	1227

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

EntryPoint Capital's LMAT Position: Q1 2026 in Review

EntryPoint Capital reduced its LeMaitre Vascular (LMAT) stake by 15% in Q1 2026, selling an estimated $79.5K and leaving 4,706 shares worth $514K. The position accounts for 0.15% of the portfolio, ranked #232.

EntryPoint Capital first reported a position in LMAT in Q4 2023 and has held it in 7 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

EntryPoint Capital held 4,706 shares of LeMaitre Vascular worth $514K as of Q1 2026.
EntryPoint Capital sold 834 LeMaitre Vascular shares in Q1 2026, an estimated $79.5K.
LeMaitre Vascular made up 0.15% of EntryPoint Capital's portfolio in Q1 2026, its #232 holding.
EntryPoint Capital first reported a position in LeMaitre Vascular in Q4 2023 and has held it in 7 quarters since.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on EntryPoint Capital's 13F filing for Q1 2026, filed 14 May 2026.